Scoperta dell'anno, per Science è lenacapivir, il farmaco che protegge dall'Hiv per sei mesi
Lenacapavir, farmaco iniettabile in fase avanzata di
sviluppo per la prevenzione dell'Hiv, è stato eletto Breakthrough of
the Year 2024. |
Italiano — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.